glutamine has been researched along with Xeroderma Pigmentosum in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Hsu, R; Lee, CN; Wong, TW | 1 |
Gomez, GVB; Lima, CSP; Lourenço, GJ; Moraes, AM; Oliveira, C; Rinck-Junior, JA; Torricelli, C | 1 |
1 review(s) available for glutamine and Xeroderma Pigmentosum
Article | Year |
---|---|
Daylight Photodynamic Therapy: An Update.
Topics: Aminolevulinic Acid; Animals; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Cheilitis; Europe; Glucose; Glutamine; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Porphyrins; Radiation Exposure; Sunlight; Time Factors; Xeroderma Pigmentosum | 2020 |
1 other study(ies) available for glutamine and Xeroderma Pigmentosum
Article | Year |
---|---|
Influence of functional variants Asp312Asn and Lys751Gln of Xeroderma Pigmentosum Group D (XPD) and Glutathione S-transferase Mu 1 (GSTM1) and Theta 1 (GSTT1) genes on cutaneous melanoma susceptibility and prognosis.
Topics: Aged; Asparagine; Aspartic Acid; Cell Survival; Disease-Free Survival; Genetic Predisposition to Disease; Genetic Variation; Genotype; Glutamine; Glutathione Transferase; Humans; Lysine; Melanoma; Middle Aged; Prognosis; Proportional Hazards Models; Skin Neoplasms; Treatment Outcome; Xeroderma Pigmentosum | 2019 |